AHSCT

PROCEDURE4 trials

Sponsors

City of Hope Medical Center, Shanghai Jiao Tong University School of Medicine, University of Calgary, European Society for Blood and Marrow Transplantation

Conditions

LymphomaMultiple SclerosisNeuromyelitis OpticaType 1 Diabetes Mellitus

Phase 1

Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients

CompletedNCT00562978

City of Hope Medical CenterLymphoma

Start: 2000-05-16End: 2018-05-21Updated: 2021-06-18

Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica

TerminatedNCT01339455

University of CalgaryNeuromyelitis Optica

Start: 2011-03-31End: 2017-03-31Updated: 2018-05-02

Phase 2

Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes

CompletedNCT00807651

Shanghai Jiao Tong University School of MedicineType 1 Diabetes Mellitus

Start: 2008-02-29End: 2016-12-31Updated: 2021-11-18

Unknown Phase

Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation

European Society for Blood and Marrow TransplantationMultiple Sclerosis

Start: 2021-01-31End: 2025-01-31Target: 50Updated: 2020-12-21

Related Papers

Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus.

2017-04-1842 citations

Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient.

2012-02-2225 citations